μ‐Opioid receptor desensitization: Is morphine different?
- 1 November 2004
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 143 (6) , 685-696
- https://doi.org/10.1038/sj.bjp.0705938
Abstract
Opioid tolerance and dependence are important phenomena. The contribution of acute mu-opioid receptor regulatory mechanisms to the development of analgesic tolerance or physical dependence are unknown, and even the mechanisms underlying relatively rapid receptor desensitization in single cells are unresolved. To a large degree, the uncertainty surrounding the mechanisms and consequences of short-term regulation of tau-opioid receptors in single cells arises from the limitations in the experimental design in many of the studies that have investigated these events. Receptor overexpression and use of assays in which regulatory mechanisms are likely to blunt control determinations have led to measurements of opioid receptor activity that are likely to be insensitive to receptor uncoupling. Together with uncertainties concerning molecular details of tau-opioid receptor interactions with potential regulatory molecules such as G protein-coupled receptor kinases and arrestins, we are left with an incomplete picture crudely copied from the well-worked-out regulatory schema for beta(2)-adrenoceptors. As a consequence, suggestions that clinically relevant tau-opioid receptor agonists may have different propensities to produce tolerance and dependence that arise from their differential recruitment of regulatory mechanisms are premature, and have not yet been appropriately assessed, nor explained in the context of a thoroughly established regulatory scheme. In this commentary, we outline the experimental limitations that have given rise to conflicting ideas about how mu-opioid receptors are regulated, and identify the issues we feel still need to be addressed before we can understand why morphine promotes receptor trafficking differently to other opioids.Keywords
This publication has 94 references indexed in Scilit:
- Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid ReceptorsPublished by Elsevier ,2003
- Endogenous RGS Protein Action Modulates μ-Opioid Signaling through GαoJournal of Biological Chemistry, 2003
- μ-Opioid Receptors Desensitize Less Rapidly than δ-Opioid Receptors Due to Less Efficient Activation of ArrestinPublished by Elsevier ,2002
- G protein-coupled receptor kinase 2 mediates µ-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnusJournal of Neurochemistry, 2001
- Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic ReceptorJournal of Biological Chemistry, 2001
- Stimulus Amplification, Efficacy, and the Operational Model. Part I—Binary Complex Occupancy MechanismsJournal of Theoretical Biology, 1999
- The Absence of a Direct Correlation between the Loss of [d-Ala2,MePhe4,Gly5-ol]Enkephalin Inhibition of Adenylyl Cyclase Activity and Agonist-induced μ-Opioid Receptor PhosphorylationPublished by Elsevier ,1999
- Tolerance to μ-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5′-O-(3-[35S]-thio)triphosphate bindingBritish Journal of Pharmacology, 1997
- The Role of Sequestration in G Protein-coupled Receptor ResensitizationJournal of Biological Chemistry, 1997
- Identification of the G Protein-coupled Receptor Kinase Phosphorylation Sites in the Human β2-Adrenergic ReceptorPublished by Elsevier ,1996